Literature DB >> 26330792

Distal ulna leiomyosarcoma treated with custom polymethylmethacrylate prosthesis with a 4-year follow-up.

Jose Arturo Pacheco-Nuñez1, Joseph E Sheppard2, Andrew P Mahoney3.   

Abstract

BACKGROUND: Intraosseous leiomyosarcoma is a rare neoplasm having an aggressive biologic behavior. The distal end of the ulna is a very uncommon site for this type of primary bone tumor frequently mistaken for benign lesions. En bloc resection of the distal ulna with reconstruction is a valid option as a limb salvage procedure for the treatment of this difficult problem, minimizing local recurrence while preserving hand function. CASE DESCRIPTION: We present an unusual case of a 63-year-old woman with a primary leiomyosarcoma arising from the distal end of the ulna treated successfully with a wide excision and custom distal ulna, with 4-year follow-up and no recurrence. LITERATURE REVIEW: Tumors to develop at the distal end of the ulna have been reported as part of large series such as Dahlin and few case reports. According to Cooney, Exner, and Mankin, reconstruction for distal ulnar neoplasms is not necessary to maintain function. However, Noble and Laurentin-Perez disagree because stabilization of the distal ulna following large resection, as in our case, can be a significant problem with associated pain and weakness due to a decreased interosseous space with ulnar stump impingement on the radial metaphysis and ulnar translation of the carpus. CLINICAL RELEVANCE: Custom methacrylate in situ radioulnar joint prosthesis for reconstruction of a large segment of the distal ulna can be a valid option to reestablish the mechanical continuity of the forearm, reducing pain and improving strength and function.

Entities:  

Year:  2015        PMID: 26330792      PMCID: PMC4551620          DOI: 10.1007/s11552-014-9725-8

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  31 in total

Review 1.  Distal ulnar prosthetic replacement.

Authors:  L R Scheker; B A Babb; P E Killion
Journal:  Orthop Clin North Am       Date:  2001-04       Impact factor: 2.472

2.  Ulnar head implant arthroplasty: an intermediate term review of 1 surgeon's experience.

Authors:  Nancy Yen Shipley; Greg R Dion; William H Bowers
Journal:  Tech Hand Up Extrem Surg       Date:  2009-09

3.  Intraosseous leiomyosarcoma arising in the epiphysis of the distal femur.

Authors:  Atsuji Matsuyama; Akio Sakamomo; Takatoshi Aoki; Masanori Hisaoka
Journal:  Pathol Res Pract       Date:  2013-06-06       Impact factor: 3.250

4.  Primary leiomyosarcoma of the femur.

Authors:  Takahiro Goto; Tsuyoshi Ishida; Noriko Motoi; Satoshi Yokokura; Hirotaka Kawano; Aiichiro Yamamoto; Koichi Matsuda; Motoi Yamamoto
Journal:  J Orthop Sci       Date:  2002       Impact factor: 1.601

5.  Is there a need for reconstruction after excision of the distal ulna for giant-cell tumour?

Authors:  Mandeep Singh Dhillon; Raghav Saini; Shivinder Singh Gill
Journal:  Acta Orthop Belg       Date:  2010-02       Impact factor: 0.500

Review 6.  Leiomyosarcoma metastases to the spine. Case series and review of the literature.

Authors:  Mohamed Samy A Elhammady; Glen R Manzano; Nathan Lebwohl; Allan D Levi
Journal:  J Neurosurg Spine       Date:  2007-02

7.  Distal ulnar tumours. Results of management by en bloc resection in nine patients and review of the literature.

Authors:  R Ferracini; E L Masterson; R S Bell; J S Wunder
Journal:  J Hand Surg Br       Date:  1998-08

8.  Distal ulna giant cell tumor resection with reconstruction using distal ulna prosthesis and brachioradialis wrap soft tissue stabilization.

Authors:  Charity S Burke; Amit Gupta; Peter Buecker
Journal:  Hand (N Y)       Date:  2009-04-16

Review 9.  Soft-tissue sarcoma.

Authors:  Nathan F Gilbert; Christopher P Cannon; Patrick P Lin; Valerae O Lewis
Journal:  J Am Acad Orthop Surg       Date:  2009-01       Impact factor: 3.020

10.  Primary leiomyosarcoma of the tibia--five years without recidivism.

Authors:  B Sestan; D Miletic; N Jonjic; I Rakovac; D Ekl; T Djapic; H Stalekar
Journal:  West Indian Med J       Date:  2007-12       Impact factor: 0.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.